Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 345,600 shares, a growth of 18.8% from the October 31st total of 291,000 shares. Currently, 5.6% of the shares of the stock are […]